COVID-19, vaccine and FDA
Digest more
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,
2don MSN
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.
Peter A. McCullough, a former cardiologist who promoted unproven treatments like ivermectin and hydroxychloroquine at the height of the pandemic, posted a video to Instagram claiming that Biden’s cancer was “turbo cancer.”
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up who have at least one underlying condition that puts them at higher risk of severe illness.
The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the risk for rare heart conditions following vaccination.
Secretary Kennedy's appointment led to fears that vaccine availability would be curtailed. Those fears are now being realized.
Almost immediately after former US president Joe Biden's office announced he had been diagnosed with an aggressive prostate cancer, anti-vaccine advocates were blaming his condition on the Covid-19 jabs he publicly received and championed.
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.